Season 07: episode 6
Tune in to the latest episode of the EMJ GOLD podcast as Isabel and Jade share a special extended version of our Catalyst interview with Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca.
In this episode, the team is joined by guest host Dr Jonathan Sackier, Host, EMJ Podcast, who caught up with Stefan at Reuters Events: Pharma 2024 in Barcelona in April.
In this extended edition of their conversation, the two unpick the current small molecule funding landscape, how to improve incentives to invest in rare diseases, how to better inform policymakers about the difference they can make and much more.
A little more on EMJ GOLD’s guest…
In Stefan’s role as SVP Europe and Canada at AstraZeneca, he is dedicated to supporting teams across 30 markets to grow the company ethically and sustainably. His focus is to improve the lives of millions of patients, with a particular emphasis on partnering to find solutions to healthcare challenges, addressing the burden of chronic disease and transforming health systems to be more future-proofed and resilient.
He’s worked at AstraZeneca for over 28 years, having joined before the merger of Astra and Zeneca in 1999, and holds a BSc and MSc in Business Administration & Economics from Stockholm University. He has additionally sat on the boards of multiple corporations, including The Swedish Chamber of Commerce and Industry in Japan, the EFPIA and most recently the Swedish Swiss Chamber of Commerce.
